Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Open Label, Cross-over Study on the Effects of Ursodeoxycholic Acid (UDCA) in Patients With Hepatic Sarcoidosis

NCT03602976 is registered in ClinicalTrials.gov with Ethan Weinberg as lead sponsor.

NCT NCT03602976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Open Label, Cross-over Study on the Effects of Ursodeoxycholic Acid (UDCA) in Patients With Hepatic Sarcoidosis
Lead sponsor
Ethan Weinberg
Phase
Phase 2
Overall status
Terminated
Start date
August 20, 2018
Completion date
January 12, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic sarcoidosis, elevated alkaline phosphatase